Pdl Biopharma Inc (PDLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2001 | 09-2001 | 06-2001 | 03-2001 | 12-2000 | |
| Sales | -2,508 | 8,055 | 12,683 | 26,170 | 17,597 |
| Gross Profit | -2,508 | 8,055 | 12,683 | 26,170 | 17,600 |
| Operating Expenses | 17,418 | 16,199 | 16,259 | 17,291 | 15,420 |
| Operating Income | -19,926 | -8,144 | -3,576 | 8,879 | 2,177 |
| Interest Expense | 2,963 | 2,248 | 2,250 | 2,248 | 2,260 |
| Other Income | 17,553 | 8,616 | 8,966 | 0 | 23 |
| Pre-tax Income | -5,336 | -1,776 | 3,140 | 6,631 | -60 |
| Net Income Continuous | -5,348 | -1,776 | 3,140 | 6,631 | -51 |
| Net Income | $-5,348 | $-1,776 | $3,140 | $6,631 | $-51 |
| EPS Basic Total Ops | -0.07 | -0.02 | 0.04 | 0.08 | N/A |
| EPS Basic Continuous Ops | -0.06 | -0.02 | 0.04 | 0.08 | 0.00 |
| EPS Diluted Total Ops | -0.05 | -0.02 | 0.03 | 0.07 | N/A |
| EPS Diluted Continuous Ops | -0.06 | -0.02 | 0.03 | 0.07 | 0.00 |
| EBITDA(a) | $-18,472 | $-6,733 | $-2,142 | $10,083 | $3,471 |